VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1652532
Sex: F
Age:
State: GA

Vax Date: 05/24/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Period seemed to stop immediately (3days instead of typical 4-5 days); Hormonal warning symptoms that period is coming, changes notice in body right before period comes; Swollen tender breasts; Swollen tender breasts; Back pain; Feel like crying easily without provocation-completely connected to hormones; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24May2021 at 15:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issues. The patient had no known allergies to medications, food or other products. The patient did not receive any concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 24May2021, the patient had period seemed to stop immediately (3days instead of typical 4-5 days), hormonal warning symptoms that period was coming, changes noticed in body right before period comes, swollen breasts, tender breasts, back pain and feel like crying easily without provocation-completely connected to hormones. It was reported that the period had not started again yet. Thankfully, it just felt like it was about to. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of period seemed to stop immediately (3days instead of typical 4-5 days), hormonal warning symptoms that period is coming, changes notice in body right before period comes, swollen breasts, tender breasts, back pain and feel like crying easily without provocation-completely connected to hormones was unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652533
Sex: M
Age:
State: IN

Vax Date: 05/17/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: 3 days after 2nd shot both legs knee on down front and back started to swell up. Feet and ankles as well.; 3 days after 2nd shot both legs knee on down front and back started to swell up. Feet and ankles as well.; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 59-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0173), dose 2 via an unspecified route of administration, administered in Arm Left on 17May2021 at 12:00 as dose 2, single for covid-19 immunisation. The patient medical history was not reported. The patient had no known allergies. Concomitant medication included VITAMINS NOS Other medications in two weeks. Historical Vaccine included bnt162b2 as 1st dose for covid-19 immunization (at the age of 59 years-old). The patient received no other vaccine in four weeks. On an unspecified date, the patient experienced 3 days after 2nd shot both legs knee on down front and back started to swell up. feet and ankles as well. Facility type vaccine was public Health Clinic/Veterans Administration facility. It was reported that 3 days after 2nd shot both legs knee on down front and back started to swell up. Feet and ankles as well. Continue to be swollen for up to two weeks and 4 days. The patient was going for an appointment to see his doctor. The patient reported it was is outrageous as it was known about this issue. Ae resulted in Doctor or other healthcare professional office/clinic visit. treatment was received Unknown. Patient was not covid prior vaccination. Patient did not test for covid post vaccination. Outcome of the events were not recovered. Follow-Up (15Jul2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652534
Sex: M
Age:
State: MD

Vax Date: 02/17/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2020; Test Name: EKG; Result Unstructured Data: Test Result:did not show any abnormal findings; Test Date: 202105; Test Name: EKG; Result Unstructured Data: Test Result:right atrial enlargement

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Mild right atrial enlargement; This is a spontaneous report from a contactable other hcp (patient). A 67-year-old male patient received bnt162b2 (BNT162B2, solution for injection, Lot number was not reported) dose number unknown via an unspecified route of administration in the left arm on 17Feb2021 11:00 (at the age of 67 years old) as dose number unknown, single for COVID-19 immunisation. The facility in which vaccination administered was other. Medical history included nephrectomy, transurethral bladder resection from 2020 (prior EKGs (3) in 2020 required for pre-op exams for bladder scrapping (2) and for right nephrectomy did not show any abnormal findings), contrast media allergy, iodized contrast dye allergy, Penicillin allergy, ureteric cancer, bladder cancer. Concomitant medications included amlodipine at 2.5 mg daily, diazepam dose unknown as needed for an unspecified indication. No other vaccines were given 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested COVID-19. On May2021 the patient experienced mild right atrial enlargement. The patient underwent lab tests and procedures on an unspecified date of 2020 which included electrocardiogram resulted did not show any abnormal findings. On May2021 which included electrocardiogram resulted right atrial enlargement. The events did not result in doctor office, emergency room or urgent care. No therapeutic measures were taken for the reported event. No treatment was given. The clinical outcome of the events was unknown. Information on lot/batch number has been requested.

Other Meds: AMLODIPINE; DIAZEPAM

Current Illness:

ID: 1652535
Sex: U
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: tinnitus; This is a spontaneous report from a contactable consumer or other non-health care professional (patient) from a Pfizer sponsored Program Pfizer.com - General Company Information. A patient of un-specified age and gender received dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced tinnitus. Patient further stated that vaccine gave me tinnitus. Was perfectly healthy. The clinical outcome of the events was reported as unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1652536
Sex: M
Age:
State: NJ

Vax Date: 05/15/2021
Onset Date: 05/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Itchy red bumpy rash all over body; Itchy red bumpy rash all over body; Itchy red bumpy rash all over body; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the right arm on 15May2021 at 12:30 as a single dose for COVID-19 immunisation. Medical history included COVID-19 infection. Concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22May2021, the patient experienced itchy, red and bumpy rash all over body. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchy, red and bumpy rash was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652537
Sex: F
Age:
State: OH

Vax Date: 05/29/2021
Onset Date: 05/29/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Soreness at injection site; injection site become raised; Tiredness; shoulder pain; left side of neck felt stiff; bruise at injection site; injection site become white; injection site numb to touch; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 29May2021 at 11:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included ankylosis spondylitis. The patient previously took Gluten and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sulfasalazine (MANUFACTURER UNKNOWN), naproxen sodium (ALEVE), sulindac (MANUFACTURER UNKNOWN), zingiber officinale (GINGER) and iron (MANUFACTURER UNKNOWN); all from an unknown date for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29May2021, the patient experienced soreness at injection site, later in the day injection site became raised and white and numb to touch. On 29May2021, 7 hours after injection, the patient had tiredness and shoulder pain (felt like it needed to pop, could not lie on it). On 29May2021, the patient experienced left side of neck stiff (woke up in the middle of the night because of pain) and bruise at injection site. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of soreness at injection site, injection site become raised and white and numb to touch, tiredness, shoulder pain, neck stiff and bruise at injection site was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SULFASALAZINE; ALEVE; SULINDAC; GINGER [ZINGIBER OFFICINALE]; IRON

Current Illness:

ID: 1652538
Sex: F
Age:
State: CA

Vax Date: 05/26/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Shortage of breath; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 26May2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient had no known allergies to food, medication or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14Apr2021, the patient experienced shortage of breath. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shortage of breath and included treatment with unspecified medications from an unspecified date in 2021 and unknown if ongoing. The clinical outcome of the event shortage of breath was not resolved at the time of this report. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1652539
Sex: F
Age:
State: NY

Vax Date: 06/05/2021
Onset Date: 06/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Headache; This is a spontaneous report from a contactable consumer. A 14-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via intramuscular route of administration in the left arm on 05Jun2021 at 14:30 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to shellfish. The patient did not receive any other medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via intramuscular route of administration in the left arm on 14May2021 at 12:30 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Jun2021 at 10:00, the patient experienced headache. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event headache was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652540
Sex: M
Age:
State: NY

Vax Date: 06/05/2021
Onset Date: 06/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Fatigue; This is a spontaneous report from a contactable consumer. A 14-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0217) via intramuscular route of administration in the left arm on 05Jun2021 at 14:45 (at the age of 14-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications in two weeks of vaccine. The patient had no known allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0217) via intramuscular route of administration in the left arm on 14May2021 at 13:45 (at the age of 14-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Jun2021 at 10:45, the patient experienced fatigue. No therapeutic measures were taken a result of the adverse event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fatigue was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1652541
Sex: F
Age:
State: NC

Vax Date: 05/17/2021
Onset Date: 05/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Hair loss, Significant hair fall that comes in sections when smoothed, brushed, washed; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17May2021 at 13:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications were not reported. It was unknown if patient was diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23May2021, the patient experienced hair loss, significant hair fall that comes in sections when smoothed, brushed and washed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the event hair loss was not recovered. No follow up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652542
Sex: F
Age:
State: AL

Vax Date: 05/20/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Extreme neck/ shoulder muscle stiffness; Extreme neck/shoulder muscle pain; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0176) via an unspecified route of administration in the right arm on 20May2021 at 17:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included ankylosing spondylitis, degenerative disc disease, chronic iridocyclitis and allergy to (Sulfa, Neomycin, Neosporin). Concomitant medications included tramadol (MANUFACTURER UNKNOWN) 50 mg one a day and B3 (MANUFACTURER UNKNOWN) one a day, both on an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21May2021, the patient experienced extreme neck/shoulder muscle pain/stiffness. No therapeutic measures were taken as a result of the reported events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme neck/shoulder muscle pain/stiffness were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: TRAMADOL

Current Illness:

ID: 1652543
Sex: M
Age:
State: AZ

Vax Date: 06/04/2021
Onset Date: 06/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data: Test Name: Fever; Result Unstructured Data: Test Result:104+ fever; Test Name: Heart rate; Result Unstructured Data: Test Result:Racing heart rate

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Racing heart rate; 104+fever; shortness of breath; Pain in Chest/Throat; Pain in Chest/Throat; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 15-years-old male patient received second dose of bnt162b2 (BNT162B2), Formulation: Solution for injection, Batch/Lot Number: EW0177; Expiration Date: Aug2021), via an intramuscular, administered in Arm Left on 04Jun2021 at 10:00 (at the age of 15-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient was 15-years-old at the time of vaccination. Facility type vaccine was Other, Facility type vaccine other was a former grocery store now, vacant/(Facility name), No other vaccine in four weeks. No, other medications in two weeks, No, covid prior vaccination, No, vaccination administered facility was not military facility. The patient medical history included autism spectrum disorder, autism spectrum disorder. There were no concomitant medications. The patient previously took amoxicillin and experienced drug hypersensitivity. The patient previously received first dose of COMIRNATY (Lot Number: EJ6134), via an Intramuscular, administered in Arm Left on 14May2021 at 10:00 AM for COVID-19 immunisation. It was reported that on 04Jun2021 22:30, the patient experienced racing heart rate, 104+fever, shortness of breath, pain in chest/throat, pain in chest/throat. No, treatment for ae. Therapeutic measures were taken as a result of racing heart rate, 104+fever, shortness of breath. No, covid tested post vaccination. Yes, treatment (NSAID, call to on call physician, cool bath). The patient underwent lab tests and procedures which included body temperature was 104+ fever, heart rate was racing heart rate. The outcome of event was recovered. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652544
Sex: M
Age:
State: CO

Vax Date: 05/30/2021
Onset Date: 06/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210606; Test Name: PCR; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 30May2021 at 00:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient has no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 02May2021 at 00:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Jun2021 at 04:00 the patient experienced fever and also got shingles two days after the second COVID vaccine dose. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On 06Jun2021, the patient underwent PCR test (nasal swab) and the result was negative. The clinical outcome of the events fever and shingles were not recovered at the time of the report. The lot number for the vaccine [BNT162b2] was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652545
Sex: F
Age:
State: TX

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Extreme joint and muscle pain in shoulders, upper arms, wrists, hands; Extreme joint and muscle pain in shoulders, upper arms, wrists, hands, and occasionally lower spine.; Extreme joint and muscle pain in shoulders, upper arms, wrists, hands; Muscle spasms in upper back and shoulders.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 12:00 (at the age of 56-years-old) as a dose 2, single for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 56-years-old) as a dose 1 for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Mar2021 at 03:00, the patient experienced extreme joint and muscle pain in shoulders, upper arms, wrists, hands and occasionally lower spine and muscle spasms in upper back and shoulders. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events extreme joint and muscle pain in shoulders, upper arms, wrists, hands and occasionally lower spine and muscle spasms in upper back and shoulders were not resolved. The batch/lot numbers for BNT162b2 were not provided and will be requested during follow-up.

Other Meds:

Current Illness:

ID: 1652546
Sex: M
Age:
State: FL

Vax Date: 06/04/2021
Onset Date: 06/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210605; Test Name: Body Temperature; Result Unstructured Data: Test Result:Fever below 100; Comments: Fever below 100

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Arm pain; Arm pain that reflected also in the back; Arm pain that reflected also in the left hand.; Fever below 100; headache; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Jun2021 at 20:00 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and hypothyroidism and penicillin allergy. Concomitant medications included metformin (MANUFACTURER UNKNOWN), semaglutide (RYBELSUS), empagliflozin (JARDIANCE), glipizide (MANUFACTURER UNKNOWN) and simvastatin (SEVERAL). The patient previously took Codeine on an unspecified date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jun2021 at 01:00, the patient experienced arm pain that reflected also in the back and left hand, fever below 100 and headache. No therapeutic measures were taken as a result of the events. The clinical outcome of the events arm pain that reflected in the back and left hand, fever below 100 and headache was resolving at the time of this report. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds: METFORMIN; RYBELSUS; JARDIANCE; GLIPIZIDE; SEVERAL

Current Illness:

ID: 1652547
Sex: F
Age:
State: IL

Vax Date: 04/09/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Excessive periods. I was in perimenopause with lighter/ cycles over past 4 yrs. Since vaccination began, I have had cycles on 01Apr, 29Apr & 05Jun which were each heavier; This is a spontaneous report from a contactable consumer reporting for herself. A 48-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 intramuscular, administered in Arm Left on 09Apr2021 16:00 (Batch/Lot Number: EW0153; Expiration Date: 31Jul2021) as dose 2, single, dose 1 intramuscular, administered in Arm Left on 17Mar2021 17:30 (Batch/Lot Number: EN6204; Expiration Date: 30Jun2021) as dose 1, single (at the age of 48-years-old) for covid-19 immunization. Medical history included menopause from Mar2017 and ongoing. Concomitant medication included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) via unspecified route in arm as single dose taken for immunization in 03Mar2021. Historical vaccine included TDAP on 17May2011 + prior via unspecified route in arm for immunization. The patient did not have any known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Pertinent details included Monthly cycle slowing X 4years. In 2020 laveraged 5 cycles of lele days long. Last period before vaccine was 31Oct2020 and cycle lasted 152 days. It was reported that, excessive periods, she was in perimenopause with lighter/shorter cycles over past 4 yrs. No cycle at all in 5 months. Since vaccination began, she has had cycles on 01Apr2021, 29Apr2021 & 05Jun2021 which were each heavier than she had had in several years. Vaccine 1 on 17Mar2021 and Period on 01Apr2021 (28 days cycle), then Vaccine 2 on 09Apr2021 and Periods on 29Apr2021 (37 days cycle). Again period on 06May2021. This one was very heavy in first 24 hours heaviest she had in year. She had made it 5 months w/o menses before vaccine triggered monthly cycles. Saw primary care physician (PCP) on 16Jun2021 but symptoms had resolved. As of 25Jul2021 still waiting on next monthly cycle but hoping frequency resumes the prior normal length. The patient did not receive any treatment for adverse event. The outcome of the event was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: T-DAP

Current Illness: Perimenopause

ID: 1652548
Sex: M
Age:
State: UT

Vax Date: 06/05/2021
Onset Date: 06/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Ears clogged and wont pop back; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 05Jun2021 at 09:15 (at the age of 16-years-old), as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included antidepressants and ADD meds from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 07May2021 at 09:00 (at the age of 16-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Jun2021 at 18:00, the patient experienced ears clogged and won't pop back (like when fly on a plane). It was unknown whether any therapeutic measures were taken as a result of the event. The clinical outcome of the event ears clogged and won't pop back was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652549
Sex: F
Age:
State: CA

Vax Date: 05/19/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: "Beginning on day 2 after first dose, extreme tiredness no matter how much sleep I get".; Always nauseated; No appetite whatsoever; "Vomiting occurred on one day only"; Vivid dreams every night; Nightmarish dreams every night; Dizziness only for the first week.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19May2021 at 18:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included COVID-19, shellfish allergy that caused severe nausea, blood pressure abnormal and ankle bloating caused due to ace inhibitors which were tried previously for BP (blood pressure) control. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included hydrochlorothiazide (HCTZ) and carvedilol (MANUFACTURER UNKNOWN); both for unknown indications from unspecified dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 21May2021, beginning on the second day after the first dose, the patient experienced extreme tiredness no matter how much sleep she got, she was always nauseated, she had no appetite whatsoever, she had vomiting which occurred on one day only, she had vivid nightmarish dreams every night which was not normal for her and dizziness only for the first week. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. The clinical outcome of the event's extreme tiredness, nauseated, no appetite, vivid nightmarish dreams was not resolved at the time of the report. The clinical outcome of the event vomiting was resolved on 22May2021. The clinical outcome of the event dizziness was resolved on an unspecified date in May2021, after the duration of a week at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds: HCTZ; CARVEDILOL

Current Illness:

ID: 1652550
Sex: M
Age:
State: DC

Vax Date: 05/27/2021
Onset Date: 05/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Flu symptoms; Full body ache; Headache; Could not function; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27May2021 at 14:00 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure/ high cholesterol and COVID-19. Concomitant medications included alfuzosin hydrochloride (MANUFACTURER UNKNOWN), olmesartan medoxomil(OMESAR), rosuvastatin (MANUFACTURER UNKNOWN) and tadalafil (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient previously took clindamycin (MANUFACTURER UNKNOWN) for unspecified indication from unknown date and experienced drug allergy. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28May2021, the patient experienced full body ache to include headache, by 24 hours patient could not function. On 29May2021, day 3, pain was subsiding. On 30May2021, by day 4, the patient experienced flu symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event full body ache, headache, could not function and flu symptoms was recovered on an unknown date of 2021. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds: ALFUZOSIN HCL; ROSUVASTATIN; TADALAFIL; OMESAR [OLMESARTAN MEDOXOMIL]

Current Illness:

ID: 1652551
Sex: M
Age:
State: TX

Vax Date: 05/02/2021
Onset Date: 05/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Vertigo; Numb hands and arms; Was sore all over; Throat closed; Trouble swallowing; Trouble breathing; Itchy feeling all over body; Bad headaches; Tingly hands and arms; Fatigue feeling/tired very easily; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0176) via an unspecified route of administration in the arm right on 02May2021 at 16:30(at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other medications within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 18:00, the patient had bad headaches within a couple of hours worst in his life for about 4 days, vertigo for 6-7 days, itchy feeling all over body, numb and tingly hands and arms. The patient was sore all over and fatigue feeling for at least 6 days. Throat closed had trouble swallowing and had trouble breathing got tired very easily. Patient was in so much pain; as patient wanted to pull his hair out. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events vertigo, numb and tingly hands and arms, sore all over, throat closed, trouble swallowing, trouble breathing, itchy feeling all over body, bad headaches and fatigue feeling/tired very easily were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652552
Sex: F
Age:
State: NC

Vax Date:
Onset Date: 03/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Severe pain in joints; This is a spontaneous report from a contactable consumer, the patient. A female patient of an unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6203) via an unspecified route of administration in the right arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history included arthritis on an unknown date. Concomitant medications were not reported. The patient previously received sulfa drugs (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced sulfonamide allergy, codeine (MANUFACTURER UNKNOWN) and morphine (MANUFACTURER UNKNOWN) both for unknown indication on unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EM9809) via an unspecified route of administration in the right arm on 02Feb2021 at 13:00 as a single dose for COVID-19 immunisation. On 05Mar2021, since the patient got the second dose the patient had severe pain in her joints. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event and included treatment with prednisolone (MANUFACTURER UNKNOWN) from an unknown date in 2021 and without relief. This pain had lasted 3 months. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe pain in joints was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652553
Sex: M
Age:
State: OH

Vax Date: 04/21/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Genital lesions appeared one week after second dose; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 37-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), second dose via an unspecified route of administration on 21Apr2021 (at the age of 37 years) as single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient had no allergies to medications, food, or other products. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. On an unspecified date 2021 the patient experienced genital lesions which appeared one week after second dose. The adverse event was resulted in Doctor or other healthcare professional office/clinic visit. Patient was treated with steroids and topical ointments for the adverse event. The outcome of the event was not recovered. The lot number for the vaccine, [bnt162b2], was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652554
Sex: F
Age:
State:

Vax Date: 06/03/2021
Onset Date: 06/03/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Sore arm; Exhaustion; Chills; Sweats; Tense muscles; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 03Jun2021 at 09:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW077) via an unspecified route of administration in the left arm on 12May2021 at 16:15 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 03Jun2021 at 22:00, the patient experienced sore arm, exhaustion, chills, sweats and tense muscles. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore arm, exhaustion, chills, sweats, and tense muscles were resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652555
Sex: F
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: COVID-19 test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Got shingles 4weeks after 2nd dose; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient experienced shingles 4 weeks after the second dose. The patient underwent COVID-19 test (nasal swab test) on an unknown date and the result was negative. Therapeutic measures were taken as a result of shingles. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event shingles was recovering at the time of reporting. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds:

Current Illness:

ID: 1652556
Sex: F
Age:
State: FL

Vax Date: 05/27/2021
Onset Date: 05/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Loss of appetite; tiredness; itching at injection site; diarrhea; and difficultywalking 1st day after vaccine.; This is a spontaneous report from a contactable consumer, the patient. An 86-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW018S) via an unspecified route of administration in the left arm on 27May2021 at 11:15 as a single dose for COVID-19 immunisation. Medical history included diabetes, hypertension and stenosis in L-5. The patient had no known allergies to medications, food or other products. Concomitant medications included metformin (MANUFACTURER UNKNOWN), glipizide (GLUCOTROL) and acetylsalicylic acid (BABY ASPIRIN) all from an unknown date for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWONO) via an unspecified route of administration in the left arm on 06May2021 at 11:15 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. On 28May2021, the patient experienced loss of appetite, tiredness itching at injection site, diarrhea, and difficulty walking 1st day after vaccine. Each subsequent day ambulation improved, then normal for patient. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included home therapies. The clinical outcomes of the events loss of appetite, tiredness itching at injection site, diarrhea, and difficulty walking were recovered on unknown date in 2021. No follow-up attempts are needed. No further information is expected

Other Meds: METFORMIN; GLUCOTROL; BABY ASPIRIN

Current Illness:

ID: 1652557
Sex: F
Age:
State:

Vax Date: 04/29/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Swelling; Anxiety attacks; Palpitations; Chest pains; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CL8729) via an unspecified route of administration in the arm left on 29Apr2021(at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included lupus syndrome, hypothyroidism, hypercholesterolemia and sulfonamide allergy. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), Levothyroxine (MANUFACTURER UNKNOWN) and hydroxychloroquine (MANUFACTURER UNKNOWN) all from an unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:EL00171) via an unspecified route of administration in the arm left on 07Apr2021(at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in May2021 the patient experienced anxiety attacks, swelling, chest pains and palpitations. No therapeutic measures were taken as a result of the events. The clinical outcome of the events anxiety attacks, swelling, chest pains and palpitations were not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: ATORVASTATIN; LEVOTHYROXINE; HYDROXYCHLOROQUINE

Current Illness:

ID: 1652558
Sex: M
Age:
State: NJ

Vax Date: 05/11/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Blood pressure; Result Unstructured Data: Test Result:124/78; Test Date: 2021; Test Name: Blood pressure; Result Unstructured Data: Test Result:119/26; Test Date: 2021; Test Name: Blood pressure; Result Unstructured Data: Test Result:126/74; Test Date: 2021; Test Name: Pulse; Result Unstructured Data: Test Result:86; Test Date: 2021; Test Name: Pulse; Result Unstructured Data: Test Result:87; Test Date: 2021; Test Name: Pulse; Result Unstructured Data: Test Result:90; Test Date: 2021; Test Name: Pulse; Result Unstructured Data: Test Result:114; Test Date: 2021; Test Name: Pulse; Result Unstructured Data: Test Result:120; Test Date: 2021; Test Name: Pulse; Result Unstructured Data: Test Result:116 to 120; Test Date: 2021; Test Name: Respiratory rate; Result Unstructured Data: Test Result:16

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: pulse rate has been a little elevated; getting out of breath; crack in the knuckle area on the second finger; rash on his left side where got shot on his hand, specifically top of hand and on his first, second, third, fourth, and fifth finger/on his first finger, thumb/high and got bright pink; there was pressure in his skull; like he was going sideways; felt like he was drugged; Palpitations; Blood pressure went down to 124/78 and so his blood pressure has been better since the vaccine; This is a spontaneous report from a contactable consumer (patient). A 52-years-old male patient received bnt162b2 (PFIZER COVID 19 VACCINE, Solution for injection, Lot Number: EW0173; Expiration Date: 31Aug2021), via an unspecified route of administration, administered in arm left on 11May2021 (at the age of 52-years-old) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Investigation Assessment was no. Caller stated he was calling about the Pfizer COVID 19 vaccine. Caller stated he had some adverse reactions to it. Caller stated the adverse reactions he experienced were palpitations, getting out of breath like when he was walking up and down the stairs especially when carrying laundry or a garbage can and he never had this problem doing that unless he had an upper respiratory infection and prior to the vaccine he was perfectly fine. Caller stated also there was a rash on his left side where he got the shot on his hand, specifically the top of hand and on his first, second, third, fourth, and fifth finger. Caller stated on his first finger, the thumb, there was a rash that started bubbling up below the middle knuckle. Caller stated he has a crack in the knuckle area on the second finger. Caller stated the rash came up high and got bright pink and then started to crack where it then popped and the same thing happened on his pinky finger. Caller stated he has a pulse ox where it does his respiratory rate and it usually holds 24 to 27 somewhere in that range but after the first vaccine it was somewhere around 16. Caller stated he also just felt like he was drugged like the vaccine was way too strong. Caller stated he felt like his blood pressure was always 135 over 78 to 80 but after the vaccine it went down to 124/78 and so his blood pressure has been better since the vaccine which was strange not supposed to be a blood thing. Caller stated like the blood pressure has even been 119/26 and 126/74. Caller stated but his pulse rate has been 86, 87, 90 so the pulse rate has been a little elevated. Caller stated he still has two major ones that he has not yet told this DSU agent which was the cranial pressure in his head within the first 4 hours going on 2 to 3 days felt like there was pressure in his skull. Caller stated the first hour or so after the vaccine he felt like he was drug and he even had caffeine and got his car cleaned, but he felt like his body was behind him like woozy to stomach like in slow motion with exertion and it felt like he was drugged. Caller stated he just wished the vaccine dosage had a high of like if it was 0.3 maybe should be 0.2. Caller stated there should be a different regimen based on height and weight. Caller stated palpitations started the same day 10 to 12 hours after getting the first shot. Caller stated it was getting somewhat better but after the second shot it got worse. Caller stated he had woken up and it had appeared after the first dose. Caller stated he got the shot on 11May2021 and it started in the middle of night around 12:20 am or 1: 00 am and 3: 00 am it woke up him. Caller stated this stopped a week to ten days after the first dose and then it came back after the second. crack in the knuckle area on the second finger: Caller stated he was scheduled for the dose around 12:20 and they had to get more vaccines and so he had to get it around 3:00pm. Caller stated this started to feel bad in the first two hours. rash got bright pink: Caller stated within that second day of getting the first dose it was pink. Caller stated within the first 24 hours he told his mom how he felt like he was drugged. Caller stated this stopped about a week or 10 days after. Felt like he was drugged: Caller stated this started within 4 hours. Caller stated he started to feel better in 5 days and then 10 days after he was completely better. Blood pressure went down to 124/78 and so his blood pressure has been better since the vaccine: Caller stated this started either 12May2021 or 13May2021. Pulse rate has been a little elevated: Caller stated on the following day his pulse rate was 114 and 120 was the highest. Caller stated after the first dose it was between 116 to 120 and after the second dose it was slightly elevated like 90 or something. Felt like there was pressure in his skull: Caller stated 10 to 12 day after the first vaccine and this got better. felt like he was going sideways: Caller stated this stopped within two days after the first dose. The patient underwent lab tests and procedures which included blood pressure measurement: 124/78, 119/26, 126/74, respiratory rate: 16, heart rate: 86, 87, 90, 114, 120 and 116 to 120 in 2021. The outcome of event Blood pressure went down to 124/78 and so his blood pressure has been better since the vaccine, felt like he was drugged and pulse rate has been a little elevated was resolving, like he was going sideways was resolved on Jun2021 and other events was not resolved. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652559
Sex: F
Age:
State: IL

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210319; Test Name: Beta blocker; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210512; Test Name: Echo; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210224; Test Name: EKG; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210308; Test Name: Holter monitor; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210224; Test Name: D-dimer; Result Unstructured Data: Test Result:Unknown result; Test Name: Pulse; Result Unstructured Data: Test Result:140 bpm-180 bpm; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20210329; Test Name: Stress echo; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210224; Test Name: Troponin; Result Unstructured Data: Test Result:Unknown result

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: anaphylactic reaction; Respiratory distress; Bilateral wheeze/bronchospasm; Shortness of breath, walking and severe if uphill/Difficulty breathing; Sudden Coughing outburst; Diarrhea; Migraine; Overall not well; Tachycardia; chest tightness; swollen left lymphnode and left breast; swollen left lymphnode and left breast; fatigue; This is a spontaneous report from a contactable Other-HCP (patient). This is one of two reports reporting the same patient/same drug with different dose (the first) and events A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EJ686), via an unspecified route of administration, administered in Arm Left on 04Jan2021 as single dose (at the age of 40) for covid-19 immunisation. No other vaccine in four weeks. No COVID prior vaccination. COVID tested post vaccination (nasal swab) was negative. Medical history included attention deficit hyperactivity disorder, gluten sensitivity, migraine. Concomitant medications included linaclotide (LINZESS), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), topiramate (TOPAMAX), ibuprofen (IBUPROFEN). The patient experienced respiratory distress on an unspecified date, anaphylactic reaction on an unspecified date, tachycardia on 04Jan2021, chest tightness on 04Jan2021, swollen left lymphnode and left breast on 04Jan2021, fatigue on 04Jan2021, bilateral wheeze/bronchospasm on an unspecified date, shortness of breath on an unspecified date, walking and severe if uphill/difficulty breathing on an unspecified date, sudden coughing outburst on an unspecified date, diarrhea on an unspecified date, migraine on an unspecified date, overall not well on an unspecified date. No treatment. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events anaphylactic reaction, respiratory distress, bronchospasm and dyspnea and the suspect drug. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds: LINZESS; ADDERALL; TOPAMAX; IBUPROFEN

Current Illness:

ID: 1652560
Sex: M
Age:
State:

Vax Date: 06/05/2021
Onset Date: 06/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: After about 25 minutes, had numbness in my tongue and a strong metallic taste; After about 25 minutes, had numbness in my tongue and a strong metallic taste; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Jun2021 at 11:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medications, food, or other products. The patient did not have any past drug history. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jun2021 at 11:30, about 25 minutes after vaccination, the patient experienced numbness in his tongue and a strong metallic taste. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events numbness in tongue and a strong metallic taste was resolved on 05Jun2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652561
Sex: M
Age:
State: TX

Vax Date: 06/01/2021
Onset Date: 06/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Body aches; Persisting neck pain; Blurred vision in left eye; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 01Jun2021 at 17:30 (at the age of 29-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient did not have a history of allergies to any food or medications or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Jun2021, next day after vaccination, the patient experienced blurred vision in left eye, persisting neck pain for multiple days. On 03Jun2021 day after vaccination, the patient experienced body aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the events. The clinical outcome of the events blurred vision in left eye, body aches and persisting neck pain were not resolved at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652562
Sex: M
Age:
State:

Vax Date: 06/02/2021
Onset Date: 06/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Cognitive issues (fogginess, short term memory retention, noticeable reduction in motor control, difficulty maintaining conversation and threading thoughts, forming sentences, etc.); Persistent headache; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Jun2021 at 16:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included crohn's. Concomitant medication included adalimumab (HUMIRA) from an unknown date and for an unknown indication. The patient previously received cefixime (SUPRAX) on an unknown date and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Jun2021 at 09:00, the patient experienced cognitive issues (fogginess, short term memory retention, noticeable reduction in motor control, difficulty maintaining conversation and threading thoughts, forming sentences, etc.) and persistent headache. The patient did not have these cognitive problems normally. The patient's persistent headache did not respond to Tylenol. The patient did get periodic headaches but they did not last that long. Therapeutic measures were not taken as a result of cognitive issues. The clinical outcome of the events cognitive issues (fogginess, short term memory retention, noticeable reduction in motor control, difficulty maintaining conversation and threading thoughts, forming sentences, etc.) and persistent headache was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: HUMIRA

Current Illness:

ID: 1652563
Sex: F
Age:
State:

Vax Date: 06/04/2021
Onset Date: 06/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Blurry vision on right peripheral; This is a spontaneous report from a non-contactable consumer, the patient. A 15-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 04Jun2021 at 09:15 (at the age of 15-years-old), as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Jun2021 at 09:30, the patient experienced blurry vision on right peripheral. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event blurry vision on right peripheral was recovered on 04Jun2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652564
Sex: F
Age:
State: OH

Vax Date: 06/01/2021
Onset Date: 06/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Stiff neck; Swollen lymph nodes; High fever; This is a spontaneous report from a contactable healthcare professional, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 01Jun2021 at 17:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high (HBP). The patient had known allergies to sulfa, fish and seafood. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paracetamol (TYLENOL) and ibuprofen (MOTRIN); both from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 11May2021 at 18:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Jun2021 at 15:00, the patient experienced stiff neck, swollen lymph nodes and high fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events stiff neck, swollen lymph nodes and high fever was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL; MOTRIN [IBUPROFEN]

Current Illness:

ID: 1652565
Sex: F
Age:
State:

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: felt light headed and dizziness the next day after the injection.; This is a spontaneous report from a contactable consumer. A 16-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in May2021(at the age of 16-years-old) as a single dose and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 04Jun2021(at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and patient had known allergy (unspecified). It was not known whether the patient had other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was not known whether the patient received any other vaccines within four weeks prior to the vaccination. On an unknown date in May2021, the patient felt light headed and dizziness the next day after the injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the event felt light headed and dizziness the next day after the injection was resolved on an unknown date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652566
Sex: F
Age:
State: CA

Vax Date: 05/28/2021
Onset Date: 05/29/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Fatigue causing 2-3 hour naps for 2 days; Very cold hands/ ice cold feet; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 28May2021 at 16:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included levothyroxine sodium (LEVOTHYROXIN) for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 23Apr2021 at 16:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29May2021 at 09:00, the patient experienced fatigue causing 2-3 hour naps for 2 days following plus 1-2 hrs resting after awakening. 1 day after, patient had very cold hands. After napping, had ice cold feet despite wearing sweatpants and being covered with a blanket while asleep. Therapeutic measures were taken as a result of the adverse events and included measures like napping for 3 hours, resting 1-2 hours and earlier bedtime. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue causing 2-3 hour naps for 2 days and very cold hands/ ice cold feet were resolved on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: LEVOTHYROXIN

Current Illness:

ID: 1652567
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Missed period for two months; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 07:30 (at the age of 28 years old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient experienced missed period for two months. Therapeutic measures were not taken as a result of the event. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event missed period for two months was resolved on an unknown date. No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652568
Sex: F
Age:
State: MO

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: bleeding; itchy skin; bruises; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 15Apr2021 at 12:00 (at the age of 30-years-old) as a single dose and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 15Apr2021 at 12:00 as a single dose for COVID-19 immunisation. Medical history included prior to the vaccination, the patient was diagnosed with COVID-19. Patient have family history of heart problems. The patient did not have any allergies to medications, food, or other products. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 18:00 the patient experienced itchy skin ever since she got the first shot and it had been a month since second vaccine and she had itchy skin like crazy and the patient itched until there were bruises and patient were bleeding. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of itchy skin and included treatment with Benadryl and allergy medication since an unknown start date to an unknown stop date. The clinical outcome of the event itchy skin, bruises,bleeding was not recovered at the time of this report. The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652569
Sex: F
Age:
State: CT

Vax Date: 06/05/2021
Onset Date: 06/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Heavy bloody nose; This is a spontaneous report from a contactable consumer, the parent. A 14-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Jun2021 at 12:00 (at the age of 14-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15May2021 at 12:00 (at the age of 14-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 05Jun2021 at 12:00, the patient experienced heavy bloody nose within 5minutes of receiving vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event heavy bloody nose was recovered on 05Jun2021. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652570
Sex: F
Age:
State: NE

Vax Date: 06/05/2021
Onset Date: 06/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210606; Test Name: body temperature; Result Unstructured Data: Test Result:101

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: fever; Chills; Sore arm; Next day woke up and threw up.; This is a spontaneous report from a non-contactable consumer, the patient. A 12-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Jun2021 at 09:15(at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history included aspergers disorder and adhd. Patient had no known allergies to food, medications or other products. The patient received unspecified other medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15May2021 at 09:00(at the age of 12-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 06Jun2021 at 05:15, the patient woke up next day and threw up and had fever, chills and sore arm. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. On 06Jun2021, the patient body temperature was measured and the result was 101(units unspecified). The clinical outcome of the event woke up next day and threw up and had fever, chills and sore arm was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652571
Sex: F
Age:
State:

Vax Date: 06/04/2021
Onset Date: 06/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Chest was heavy; Heart was racing; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Jun2021 at 17:45 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received SEPTRA and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Jun2021 at 18:00 the patient's chest was heavy and heart was racing which she had never experienced before for which she ended up at the emergency room around 19:00. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of chest heaviness and heart racing and included treatment with unknown medications for both blood pressure and heart. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events chest heaviness and heart racing were not recovered at the time of reporting. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652572
Sex: F
Age:
State: MA

Vax Date: 06/03/2021
Onset Date: 06/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Severe headache; Pain at the injection site; Body aches severe; Digestive distress; Stomach ache; Feeling of needing to vomit; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the right arm on 03Jun2021 at 16:30 (at the age of 16 years old) as a single dose for COVID-19 immunisation. Medical history included peanut allergy and corn allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 13May2021 at 16:15 (at the age of 15 years old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Jun2021 at 01:00, the patient experienced severe headache, pain at the injection site, body aches severe, digestive distress, stomach ache and the feeling of needing to vomit. Therapeutic measures were taken as a result of the events which included treatment with ADVIL. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events severe headache, pain at the injection site, body aches severe, digestive distress, stomach ache and the feeling of needing to vomiting was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652573
Sex: F
Age:
State: CA

Vax Date: 05/28/2021
Onset Date: 06/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Persistent twitch of eyelid right eye; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 28May2021 at 12:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications included unspecified multivitamins from an unknown date and for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 07May2021 at 12:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Jun2021 at 09:00, the patient experienced persistent twitch of eyelid right eye. The patient did not receive any treatment for the reported event. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event persistent twitch of eyelid right eye was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds:

Current Illness:

ID: 1652574
Sex: F
Age:
State:

Vax Date: 02/14/2021
Onset Date: 02/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Tingling in legs, pins and needle in legs; hard heavy legs feeling; high blood presure; brain fog; heart palpations; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 14Feb2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if the patient had been tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Feb2021, the patient experienced tingling in legs, hard heavy legs feeling, pins and needle in legs, high blood pressure, brain fog and heart palpations. The events resulted in doctor or other healthcare professional office/clinic visit, emergency visit room/department or urgent care. Therapeutic measures were not taken as a result of adverse events. The clinical outcome of the events tingling in legs, hard heavy legs feeling, pins and needle in legs, high blood pressure, brain fog and heart palpations were resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1652575
Sex: M
Age:
State: MN

Vax Date: 06/04/2021
Onset Date: 06/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: moderate joint pain; low fever; blurred vision.; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 04Jun2021 at 14:15 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included exercise induced asthma and allergy to gluten. Concomitant medications included quetiapine fumarate (SEROQUEL) from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14May2021 at 13:15 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jun2021 at 09:00, the patient experienced moderate joint pain, low fever and blurred vision. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events moderate joint pain, low fever and blurred vision was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: SEROQUEL

Current Illness:

ID: 1652576
Sex: F
Age:
State:

Vax Date:
Onset Date: 06/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Very poor sleep; Sense of dread/ Worried that she was dying and heart was going to explode; Heart palpitating and racing; Very tired; Soreness in arm where the vaccine was injected; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN; lot unknown reason: other) via an unspecified route of administration on an unknown date (at the age of 33-year-old) as a single dose for COVID-19 immunisation. The patient medical history included bronchitic asthma, ventricular septal defect and heart murmur. The patient was allergic to latex. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Jun2021 at 05:15, the patient experienced very poor sleep, felt a sense of dread and then heart palpitating and racing, which woke her up. She was worried that she was dying and heart was going to explode, very tired and worried. This has been her only noticeable side effect besides soreness in her arm where the vaccine was injected. The clinical outcome of the events very poor sleep, felt a sense of dread and then heart palpitating and racing, which woke her up, she was worried that she was dying and heart was going to explode very tired and worried soreness in arm where the vaccine was injected was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652577
Sex: F
Age:
State: WV

Vax Date: 06/03/2021
Onset Date: 06/03/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Monday morning I started to feel dizzy and nauseous; Monday morning I started to feel dizzy and nauseous; headache started almost immediately after receiving the vaccine; This is a spontaneous report from a contactable consumer (Patient) reporting for herself. A 36-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EW0217; Expiration date was not reported), via an unspecified route of administration, in Left Arm on 03Jun2021 15:00 (at the age of 36-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug store. The patient medical history included depression, panic disorder, injury, stress (trauma and stressor related disorder), asthma, glucose tolerance impaired (prediabetes), obesity from an unknown date and unknown if ongoing. The patient had no known allergies and the patient did not receive other vaccine in four weeks, The patient was not diagnosed covid prior vaccination, The patient had not been tested for covid, post vaccination. The patient concomitant medications included buspirone hydrochloride (BUSPAR); fluoxetine hydrochloride (PROZAC); loratadine (LORATADINE); fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) taken for an unspecified indication, start and stop date were not reported. The patient experienced headache started almost immediately after receiving the vaccine on 03Jun2021, Monday morning patient started to feel dizzy and nauseous on 07Jun2021 07:00. The patient did not received treatment for the events. Clinical outcome of the events was unknown. Follow-up attempts are completed. No further information is expected

Other Meds: BUSPAR; PROZAC; LORATADINE; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1652578
Sex: M
Age:
State: CT

Vax Date: 06/03/2021
Onset Date: 06/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Chills; nausea; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 03Jun2021(at the age of 13-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as unknown. It was unknown if patient had any allergies. It was unknown if patient received any other medication within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unknown route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 04Jun2021, the patient experienced chills and nausea. It was unknown whether therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event chills and nausea was resolved on an unknown date in Jun2021. The batch/lot numbers for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652579
Sex: F
Age:
State:

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: total distortion of smell/smells putrid and horrible; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old nonpregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 15Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 in Jan2021. Concomitant medications were not reported. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021, the patient waited 3 months to get vaccinated and after the second vaccine had total distortion of smell. Everything smelled putrid and horrible. Coffee, onions, bread and much more smells horrible which made hard for to eat. This had really been a horrible experience and didn't happen until had the vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event total distortion of smell, everything smells putrid and horrible was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652580
Sex: F
Age:
State: VA

Vax Date: 03/11/2021
Onset Date: 03/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: red hives from wrist to above elbows on both arms less than 5 minutes after injection.; broke out in red hives from wrist to above elbows on both arms less than 5 minutes after injection.; week later the injection site was red; a week later the injection site was red and inflamed in about a half inch circle took over a week to heal.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 11Mar2021(at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, TBI(traumatic brain injury) and heart blockage. The patient received other medications(unspecified) within two weeks of vaccination. The patient previously took amoxicillin, clavulanic acid (AUGMENTIN), metformin hydrochloride (GLUCOPHAGE), metformin(MANUFACTURER UNKNOWN) on unknown dates and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 less than 5 minutes after injection, the patient experienced red hives from wrist to above elbows on both arms. On an unknown date in Mar2021 a week later, the patient's injection site was red and inflamed in about a half inch circle and took over a week to heal and left a scar. Therapeutic measures were taken as a result of reported events which included treatment with Benadryl administered multiple doses by a pharmacist. The clinical outcome of the event red hives, the injection site red (vaccination site erythema) and inflamed in about a half inch circle (vaccination site inflammation) was recovered with sequelae on an unknown date in 2021 at the time of this report. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652581
Sex: M
Age:
State: FL

Vax Date: 06/06/2021
Onset Date: 06/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210607; Test Name: body temperature; Result Unstructured Data: Test Result:102.3

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Severe Pain In Left ArmFever Of 102.3Pain At Injection Site; fever; injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 06Jun2021 at 12:30 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 16May2021 at 12:30 hours (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included montelukast sodium (SINGULAIR) once a day and ascorbic acid, pyridoxal phosphate, biotin, folic acid, colecalciferol, calcium pantothenate, ascorbyl palmitate, cocarboxylase, calcium citrate, tocopheryl acid succinate, calcium ascorbate, magnesium aspartate, betacarotene, manganese, molybdenum, chromium, copper, vanadium, iodine, selenium, mecobalamin, magnesium ascorbate, zinc gluconate, bioflavonoids nos, nicotinamide ascorbate, riboflavin phosphate, boron citrate (CHILDREN'S MULTIVITAMIN) from unknown date for unknown indication and unknown if ongoing in last 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Jun2021 at 02:00 the patient experienced severe pain in Left arm, fever and injection site pain. The patient did not receive any treatment for the event. On 07Jun2021, the patient underwent body temperature and the result was 102.3. The clinical outcome of the event severe pain in Left arm, fever and injection site pain was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: SINGULAIR; CHILDREN'S MULTIVITAMIN

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am